Lentivirus Packaging for Cell and Gene Therapy Research
Optimize gene therapy and CAR-T research with end-to-end lentiviral packaging, titering, plasmid design, and storage for gene therapy research
Lentiviral Vector Packaging for Enhanced Downstream Research
Lentiviral vectors (LVs) are indispensable tools in gene therapy, CAR-T engineering, and functional genomics. Despite the technical complexity of the lentivirus packaging process, lentiviral vectors offer key advantages over traditional retroviral systems, including efficient transduction of both dividing and non-dividing cells and durable long-term gene expression.
To help researchers produce consistent, high-titer lentiviral vectors, GENEWIZ from Azenta Life Sciences offers a comprehensive, end-to-end lentiviral packaging workflow. From plasmid construct design and DNA synthesis to viral packaging, titering, and storage, our integrated services enable fast, reliable results for downstream gene therapy and cell engineering applications.
Explore the Five Essential Steps of Lentiviral Vector Production
-
Plasmid Construct Design
Build safe, efficient lentiviral expression constructs optimized for your gene of interest.
-
DNA Synthesis
Leverage codon-optimized, error-free synthetic DNA to improve gene expression and production success.
-
DNA Cloning and Plasmid Preparation
Generate high-quality plasmids engineered for stable, reproducible lentiviral packaging.
-
Lentivirus Packaging and Titering
Produce functional, high-titer lentiviral particles using optimized co-transfection and accurate titer measurement.
-
Plasmid & Lentivirus Storage
Ensure long-term sample stability with validated storage and handling conditions.
Download Infographic
Related Synthesis Services
Custom viral packaging with scalable production, high titers, and rigorous QC testing.
High-accuracy custom gene synthesis, cloning, and sequence design services.
Scalable plasmid DNA preparation with high yield and purity options.